Clinical Trial

Adults With Constipation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This randomized, double-blind, placebo-controlled trial will assess the clinical effects of Akk09 in adults with functional constipation. Participants will receive Akk09 or placebo for 8 weeks. The study will evaluate changes in bowel habits and symptom burden, as well as alterations in host inflammatory status, immune modulation, microbial ecosystem dynamics, neuroendocrine signaling related to the gut-brain axis, and systemic metabolic responses, to characterize the overall physiological impact of Akk09 supplementation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-04-07; most recent amendment 2026-07-23.
Trial Details
NCT Number NCT07529457
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Constipation
Enrollment 70 participants
Start Date 2026-07-24
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-05-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-24